A targeting construct was engineered to incorporate a mutation of Thrb into the endogenous locus. The construct contained a frameshift mutation followed by a portion of human THRB obtained from a patient with resistance to thyroid hormone (RTH). Expression of the mutant allele was confirmed by Northern blot analysis. (J:73446)